{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:47:39Z","timestamp":1767134859550,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd004312","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2005,1,24]],"date-time":"2005-01-24T00:00:00Z","timestamp":1106524800000}}],"reference-count":20,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004312.pub2","type":"journal-article","created":{"date-parts":[[2005,1,17]],"date-time":"2005-01-17T02:17:07Z","timestamp":1105928227000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Botulinum toxin type A versus anticholinergics for cervical dystonia"],"prefix":"10.1002","author":[{"given":"Jo\u00e3o","family":"Costa","sequence":"first","affiliation":[{"name":"Faculdade de Medicina de Lisboa; Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica; Av. Prof. Egas Moniz Lisboa Portugal 1649-028"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia C","family":"Esp\u00edrito-Santo","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina de Lisboa; Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica; Av. Prof. Egas Moniz Lisboa Portugal 1649-028"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana A","family":"Borges","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina de Lisboa; Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica; Av. Prof. Egas Moniz Lisboa Portugal 1649-028"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Moore","sequence":"additional","affiliation":[{"name":"NHS Trust; The Walton Centre for Neurology and Neurosurgery; Lower Lane Liverpool UK L9 7LJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina de Lisboa; Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica; Av. Prof. Egas Moniz Lisboa Portugal 1649-028"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel M","family":"Coelho","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina de Lisboa; Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica; Av. Prof. Egas Moniz Lisboa Portugal 1649-028"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Sampaio","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina de Lisboa; Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica; Av. Prof. Egas Moniz Lisboa Portugal 1649-028"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,1,24]]},"reference":[{"key":"10.1002\/14651858.CD004312.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1212\/WNL.46.4.1066","article-title":"Botulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trial","volume":"46(4)","author":"Brans","year":"1996","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004312.pub2-BIB0002|cit2","article-title":"Electromyography before and after botulinum toxin versus trihexyphenidyl in cervical dystonia","volume":"13 Suppl 2","author":"Brans","year":"1998","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD004312.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1212\/WNL.51.3.815","article-title":"Electromyography in cervical dystonia: changes after botulinum and trihexyphenidyl","volume":"51","author":"Brans","year":"1998","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004312.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/bmj.313.7055.486","article-title":"Statistics notes. Interaction 1: Heterogeneity of effects","volume":"313(7055)","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004312.pub2-BIB0005|cit5","volume-title":"Scientific and Therapeutic Aspects of Botulinum Toxin","author":"Brin","year":"2002"},{"key":"10.1002\/14651858.CD004312.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/mds.870060206","article-title":"Idiopathic cervical dystonia: clinical characteristics","volume":"6","author":"Chan","year":"1991","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD004312.pub2-BIB0007|cit7","first-page":"29","article-title":"Botulinum toxin type A for the treatment of cervical dystonia: a systematic review","volume":"15,Suppl 3","author":"Costa","year":"2000","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD004312.pub2-BIB0008|cit8","first-page":"295","article-title":"The treatment of Spasmodic torticollis","volume-title":"In: Quinn NP, Jenner PG, eds. Disorders of movement","author":"Cullis","year":"1989"},{"key":"10.1002\/14651858.CD004312.pub2-BIB0009|cit9","first-page":"787","article-title":"The Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group","volume":"247","author":"ESDE","year":"2000","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD004312.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3171\/jns.1959.16.1.0055","article-title":"Experimental spasmodic torticollis","volume":"16","author":"Foltz","year":"1959","journal-title":"Journal of Neurosurgery"},{"key":"10.1002\/14651858.CD004312.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/archneur.1990.00530050070014","article-title":"Natural history of adult-onset idiopathic torticollis","volume":"47","author":"Jahanshahi","year":"1990","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD004312.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1212\/WNL.41.7.1088","article-title":"Cervical dystonia: clinical findings and associated movement disorders","volume":"41","author":"Jankovic","year":"1991","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004312.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00415-003-0942-2","article-title":"Abnormalities of cortical excitability and cortical inhibition in cervical dystonia Evidence from somatosensory evoked potentials and paired transcranial magnetic stimulation recordings","volume":"250(1)","author":"Kanovsky","year":"2003","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD004312.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1067300","article-title":"Midbrain control of three-dimensional head orientation","volume":"295(5558)","author":"Klier","year":"2002","journal-title":"Science"},{"key":"10.1002\/14651858.CD004312.pub2-BIB0015|cit15","doi-asserted-by":"crossref","unstructured":"Kreyden OP Botulinum Toxin: From Poison to Pharmaceutical The History of a Poison That Became Useful to Mankind In Kreyden OP, B\u00f6ni R, Burg G (eds): Hyperhidrosis and Botulinum Toxin in Dermatology. Current Problems in Dermatology. Basel, Karger, 2002, 30: 94-100.","DOI":"10.1159\/000060669"},{"key":"10.1002\/14651858.CD004312.pub2-BIB0016|cit16","first-page":"313","volume-title":"Drug treatment of dystonia. In: Quinn NP, Jenner PG, eds. Disorders of movement","author":"Lang","year":"1989"},{"key":"10.1002\/14651858.CD004312.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/mds.870030302","article-title":"Epidemiology of focal and generalized dystonia in Rochester, Minnesota","volume":"3(3)","author":"Nutt","year":"1988","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1002\/14651858.CD004312.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/mds.870120117","article-title":"Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin","volume":"12","author":"Tarsy","year":"1997","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD004312.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","article-title":"Double-blind study of botulinum toxin in spasmodic torticollis","volume":"ii","author":"Tsui","year":"1986","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004312.pub2-BIB0020|cit20","first-page":"211","volume-title":"Clinical assessments of patients with cervical dystonia","author":"Consky","year":"1994"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004312.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004312.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:33:13Z","timestamp":1628530393000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004312.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Movement Disorders Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2005,1,24]]},"references-count":20,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004312.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,24]]}}}